Pharma 65: Cancer Pharmacotherapy - Treating Growth Without Losing the Host

This episode introduces cancer pharmacotherapy as the discipline of constrained aggression. Unlike infections, cancer arises from the host’s own cells-meaning therapy must discriminate between malignant growth and essential renewal. We explore the fundamental principles that govern oncology treatment: cell-cycle vulnerability, therapeutic index, combination regimens, resistance, and the logic of dosing schedules. The emphasis is not on individual drugs, but on strategy: why sequencing, intent (curative vs palliative), and patient context define success more than potency alone.Key takeaways to frame the oncology section:* The central paradox: killing cancer without killing the patient.* Cell-cycle logic: why timing and phase specificity matter.* Combination rationale: synergy, resistance prevention, and toxicity balancing.* Therapeutic index: dose intensity versus tolerability.* Clinical intent: cure, control, or comfort-and how that changes decisions. This is a public episode. If you'd like to discuss this with other subscribers or get access to bonus episodes, visit drmanaankarray.substack.com/subscribe